Dr. Andree K. Bates outlines what oncology marketers need to do to ensure commercial success
Angelo DePalma explores prescription to over-the-counter (Rx to OTC) switches as a strategy for extending a product’s commercial life
Todd Johnson of Kantar Health outlines how market research can be honed into reliable data to improve forecasts
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
How I learned to love the iPad a little bit less
Patients need to know the risks of non-adherence as much as the risks of medication
Eyeforpharma's Ursula Sautter talks to Rafael Quintanilla Chong, head of primary care at Bayer Healthcare Mexico, about the promise of the Latin American market
Teenagers with cancer often report feelings of isolation, bitterness, confusion, pain, and fear as they struggle through a life-threatening disease before their lives have taken full shape.
Six novel ways pharma can identify and engage with key opinion leaders (KOLs)
Angelo DePalma explores what it costs to bring a new drug to market—and why it matters
Teenagers with cancer often report feelings of isolation, bitterness, confusion, pain, and fear as they struggle through a life-threatening disease before their lives have taken full shape.
Are you an ‘MBA clone’? Dr. Andrée K Bates explores how de-cloning yourself does wonders for your ability to thrive in competitive markets
Professors John Weinman of Kings College London and Keith Petrie of the University of Auckland on the future of medication adherence
In the first of a two-part series, Dr. Andree K. Bates explores how changes to the drug and technology can improve patient adherence
Teenagers with cancer often report feelings of isolation, bitterness, confusion, pain, and fear as they struggle through a life-threatening disease before their lives have taken full shape.
Milos Graonic, senior vice president, global leader of Nielsen BASES Pharmaceutical Practice, on how to mine patient data for forecasting insights
Prasad Saraph, business partner at Bayer HealthCare, explains why forecasting must reflect an organization’s collective intelligence
Peter Mansell reports on how to balance complexity and predictability when forecasting for biologics
Dr. Andree K. Bates outlines key strategies for addressing the sales, marketing and market access challenges of the oncology market
Paolo Morgese of Merck Serono and Peter Wagner and Maximilian Schwarz of Mederi present 5 tips for matching stakeholders’ value expectations with demonstration of value
Leela Barham reports on how the pharma industry can make the most of working with emerging stakeholders
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Kevin Appareti, Global Director Medical Science Liaison at Philips Healthcare, gives a short but useful interview on his company's approach to KOL engagement